Login / Signup

Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers.

Sigrid LundgrenKarl WallblomJane FisherSusanne ErdmannArtur SchmidtchenKarim Saleh
Published in: BMJ open (2023)
NCT05378997.
Keyphrases
  • double blind
  • wound healing
  • placebo controlled
  • clinical trial
  • phase iii
  • phase ii
  • study protocol
  • pulmonary artery
  • open label
  • aortic dissection
  • coronary artery